socalTECH

AUGUST 4, 2014

San Diego-based Otonomy , which is developing treatments for diseases of the inner and middle ear, set its estimated IPO pricing range Friday. The company is venture backed by Avalon Ventures, OrbiMed, Novo AS, TPG Biotech, Domain Associates, Rivervest Venture Partners, as well as others. and $16.00 READ MORE>>.

Pricing 147

Pricing Avalon San Diego Acquisition 147

socalTECH

FEBRUARY 5, 2014

Goleta-based medical equipment maker Inogen has set the pricing range for its IPO, saying in a filing with the SEC that it expects its stock to price at between $16.00 Inogen is venture backed by Novo AS, Versant Ventures, Arborteum Ventures, Avalon Ventures, and Accuitive Medical Ventures. and $18.00 READ MORE>>.

Avalon 214

Avalon Pricing Acquisition Marketing 214

socalTECH

JANUARY 17, 2017

San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has set its estimated IPO pricing range, saying on Tuesday that it expects to price its IPO at between $14.00 and $16.00 The company is selling 4,000,000 shares of its common stock on the NASDAQ Global Select Market as ANAB. as early as Thursday.

Pricing 100

Pricing Avalon Southern California Venice 100

socalTECH

JUNE 11, 2021

La Jolla-based biopharmaceuticals startup Janux Therapeutics said early this morning that it has priced its IPO, offering up 11,400,000 shares of its common stock at $17.00 The company's biggest shareholders before the IPO were Avalon Ventures, RA Capital Healthcare, Orbimed, Bregua Corporation, and Correlation Ventures.

Pricing 113

Pricing Avalon Capital Marketing 113

socalTECH

AUGUST 13, 2014

San Diego-based biopharmaceuticals firm Otonomy was up today in early trading, after pricing 6.25 The company priced at the high end of its initial estimated IPO range, which was $14.00 The company priced at the high end of its initial estimated IPO range, which was $14.00 million shares of its common stock at $16.00

Avalon 138

Avalon San Diego Pricing Acquisition 138

socalTECH

DECEMBER 16, 2011

Among the biggest winners of the IPO of Zynga is San Diego-based Avalon Ventures , which owned 32,169,401 shares of Zynga before the IPO, a stake which was worth $321M based on Zynga's opening price this morning. Zynga priced at $10.00 Zynga looks to be among the most visible exits from that firm's portfolio yet.

Southern California 145

Southern California SoCal Avalon San Diego 145

socalTECH

JANUARY 26, 2017

Anaptys priced its IPO on Wednesday night at $15.00 AnaptysBio is backed by Frazier Healthcare, Novo A/S, Avalon Ventures, Alloy Ventures, Biotechnology Value Fund, HBM Healthcare Investments, and others. San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has raised $75.0M

Avalon 100

Avalon San Diego Pricing Invest 100